COVID-19

Guidehouse Research Estimates Global Market for Air Quality Technologies in Commercial Buildings Will Grow to Nearly $419 Billion by 2033

Health awareness, which surged after the COVID-19 pandemic, is key market driver BOULDER, Colo., July 16, 2025 /PRNewswire/ -- A new report…

5 months ago

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July…

5 months ago

FORMER U.S. SECRETARY OF HEALTH AND HUMAN SERVICES, TOMMY THOMPSON VISITS DR. HOWARD ZUCKER’S “DOCOLOGY” PODCAST ON MONDAY, JULY 14

NEW YORK, July 10, 2025 /PRNewswire/ -- Former U.S. Secretary of Health and Human Services Tommy Thompson will join host Dr.…

6 months ago

Fifty1 AI Labs’ REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership

Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks Transformative Therapies and Drives Path to $50M ValuationSEATTLE, July 10, 2025…

6 months ago

Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project

VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased…

6 months ago

Osivax Publishes Phase 2a Results Supporting Co-Administration of OVX836 with Seasonal Flu Vaccine in Vaccines Journal

Co-administration of OVX836 with seasonal inactivated influenza vaccine (Fluarix® Tetra) was well-tolerated and demonstrated a favorable safety profileRobust complementary immune…

6 months ago

BAYADA, ECPI University partner to alleviate nursing shortage with joint training, $355,000 in scholarships

BAYADA's investment will fund education for 35+ LPNs and RNs at ECPI University's Columbia campus COLUMBIA, S.C., July 9, 2025…

6 months ago

Hemostemix Oversubscribed, Closing $2,700,000 Private Placement and Settles $400,000 of Debt at $0.20 per Share

Calgary, Alberta--(Newsfile Corp. - July 9, 2025) - Hemostemix Inc's (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

6 months ago

Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies

Phase 1/2 clinical study evaluating seclidemstat in patients with MDS and CMML is progressing with updates expected later this year…

6 months ago

The Anosh Foundation Launches Global Oversight Initiative to Strengthen COVID-19 Testing and Vaccination Integrity

Nonprofit organization enhances international COVID response efforts with new compliance and quality assurance measures. Image of Dr. Anosh Ahmed CHICAGO,…

6 months ago